New Issue: RBC prices $410,000 bullish barrier enhanced notes linked to five stocks

By Angela McDaniels

Tacoma, Wash., Oct. 20 – Royal Bank of Canada priced $410,000 of 0% bullish barrier enhanced return notes due Oct. 13, 2017 linked to a basket of stocks, according to a 424B2 filing with the Securities and Exchange Commission.

The basket is comprised of the common stocks of Amgen Inc., Gilead Sciences, Inc., Johnson & Johnson, Merck & Co., Inc. and Pfizer Inc.

The payout at maturity will be par plus 200% of any basket gain, up to a maximum return of 24%. If the basket falls by 20% or less, the payout will be par. If the basket declines by more than 20%, investors will be fully exposed to the loss.

RBC Capital Markets, LLC is the underwriter.

Issuer:	Royal Bank of Canada
Issue:	Bullish barrier enhanced return notes
Underlying stocks:	Amgen Inc., Gilead Sciences, Inc., Johnson & Johnson, Merck & Co., Inc. and Pfizer Inc.
Amount:	$410,000
Maturity:	Oct. 13, 2017
Coupon:	0%
Price:	Par
Payout at maturity:	Par plus 200% of any basket gain, up to 24% maximum return; if basket falls by 20% or less, par; if basket declines by more than 20%, full exposure to decline
Pricing date:	Oct. 16
Settlement date:	Oct. 21
Underwriter:	RBC Capital Markets, LLC
Fees:	2.25%
Cusip:	78012KHU4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.